NATURAL ALTERNATIVES INTERNATIONAL INC Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of -$73.00 thousand for the 12-month period ending 2017-06-30, per its 10-K filed 2018-09-19.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2018-09-19
- NATURAL ALTERNATIVES INTERNATIONAL INC effective income tax rate reconciliation, other adjustments, amount for fiscal 2017 was -$73.00K.
- NATURAL ALTERNATIVES INTERNATIONAL INC effective income tax rate reconciliation, other adjustments, amount for fiscal 2016 was -$61.00K.
- NATURAL ALTERNATIVES INTERNATIONAL INC effective income tax rate reconciliation, other adjustments, amount for fiscal 2015 was -$46.00K.
- NATURAL ALTERNATIVES INTERNATIONAL INC effective income tax rate reconciliation, other adjustments, amount for fiscal 2014 was -$34.00K.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month as first filed |
|---|---|---|
| 2017-06-30 | -$73.00K 10-K · filed 2018-09-19 | -$79.00K 10-K · filed 2017-09-18 |
| 2016-06-30 | -$61.00K 10-K · filed 2017-09-18 | |
| 2015-06-30 | -$46.00K 10-K · filed 2016-09-19 | |
| 2014-06-30 | -$34.00K 10-K · filed 2015-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNATECH INC (MTEX) | United States | $0.014B | |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |